Study, Country, and Site Feasibility

A Standardized, Data-Driven Approach to Faster, Smarter Study Planning

Princeton Blue helped a global biopharmaceutical leader modernize its approach to clinical study feasibility and site identification. By replacing fragmented knowledge, manual data gathering, and inconsistent workflows with a centralized automation platform, teams gained real-time insight, standardized governance, and a scalable foundation for smarter study planning.

Challenges

Study feasibility and site identification are foundational steps in the clinical trial lifecycle. Before a trial can begin, sponsors must evaluate where the study can realistically succeed, considering patient availability, investigator experience, infrastructure readiness, compliance requirements, and historical site performance. As clinical research expands across more therapeutic areas, geographies, and increasingly complex protocols, feasibility planning becomes more difficult to manage through manual processes and disconnected systems.

Our client, a global biotechnology and pharmaceutical company, needed a modern solution that could centralize feasibility knowledge, standardize workflows, and provide real-time insights throughout the site identification process.

Fragmented Data and Tribal Knowledge

Fragmented Data and Tribal Knowledge

Feasibility insights were spread across multiple internal systems, with no centralized knowledge base.
Manual and Time Consuming Search

Manual and Time-Consuming Search

Identifying comparable studies, prior country performance, or site history required teams to manually search through diverse data sources.
Lack of a Connected Data Fabric

Lack of a Connected Data Fabric

Without a consolidated view, teams could not easily analyze feasibility outcomes across therapeutic areas, countries, or sites.
High Communication Burden Across Stakeholders

High Communication Burden Across Stakeholders

With no structured system for collaboration and documentation, communication management became a significant burden.
Limited Visibility Into Status and Bottlenecks

Limited Visibility Into Status and Bottlenecks

Because workflows were not standardized, teams lacked consistent project-level visibility into feasibility progress, delays, risks, or outstanding decisions, slowing down site onboarding and planning cycles.

Solution

Princeton Blue implemented a solution on the Appian Low-Code Process Automation platform, leveraging both workflow automation and data fabric capabilities to transform the feasibility and site identification lifecycle.

Standardized flexible workflow

Standardized, flexible workflow

A structured workflow that guides users through key feasibility stages, while automated routing and governance ensures consistency.
Centralized Knowledge

Centralized Knowledge

All data, deliverables, and interactions were systematically tagged and stored, creating a unified knowledge base that could be searched and reused across future studies.
Data Aggregation and Decision Support

Data Aggregation and Decision Support

The platform provided feasibility teams with relevant aggregated data displayed in a meaningful and easy-to-consume format.
Dynamic Dashboards and Visual Analytics

Dynamic Dashboards and Visual Analytics

Princeton Blue delivered consolidated dashboards that gave stakeholders real-time visibility into feasibility progress and risk areas.

Impact

With the new solution, the client established a scalable, standardized, and insight-driven approach to study feasibility and site identification.

Key outcomes included:

  • Full visibility into feasibility projects, data, documents, and status
  • Reduced manual effort in searching and assembling feasibility evidence
  • Improved collaboration through structured workflows and notifications
  • Centralized data fabric integrating internal and external study insights
  • Faster, more confident country and site selection decisions
  • Real-time monitoring of bottlenecks and process inefficiencies
  • A foundation for scaling feasibility operations across growing clinical portfolios

Ultimately, the organization improved operational efficiency, decision quality, and speed to site onboarding.

Get Started Today

Contact Us
Scroll to Top